Trade Castle Biosciences, Inc. - CSTL CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.36 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023512% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.00129% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 25.95 |
| Open | 26.19 |
| 1-Year Change | 4.76% |
| Day's Range | 25.55 - 26.44 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Feb 21, 2025 | 25.55 | -0.15 | -0.58% | 25.70 | 26.52 | 25.55 |
| Feb 20, 2025 | 25.95 | -0.70 | -2.63% | 26.65 | 26.78 | 25.75 |
| Feb 19, 2025 | 26.90 | 0.50 | 1.89% | 26.40 | 27.42 | 25.95 |
| Feb 18, 2025 | 26.49 | -0.71 | -2.61% | 27.20 | 27.64 | 26.46 |
| Feb 14, 2025 | 27.23 | -0.22 | -0.80% | 27.45 | 27.73 | 26.94 |
| Feb 13, 2025 | 27.42 | -0.27 | -0.98% | 27.69 | 28.27 | 26.19 |
| Feb 12, 2025 | 27.55 | 0.45 | 1.66% | 27.10 | 28.17 | 27.10 |
| Feb 11, 2025 | 27.91 | 0.51 | 1.86% | 27.40 | 28.12 | 26.92 |
| Feb 10, 2025 | 27.64 | 0.38 | 1.39% | 27.26 | 28.17 | 27.20 |
| Feb 7, 2025 | 27.39 | -0.24 | -0.87% | 27.63 | 27.93 | 27.16 |
| Feb 6, 2025 | 27.75 | 0.15 | 0.54% | 27.60 | 28.39 | 27.38 |
| Feb 5, 2025 | 28.07 | 0.00 | 0.00% | 28.07 | 28.42 | 27.25 |
| Feb 4, 2025 | 28.10 | -0.07 | -0.25% | 28.17 | 28.77 | 27.47 |
| Feb 3, 2025 | 28.62 | 1.47 | 5.41% | 27.15 | 28.80 | 26.79 |
| Jan 31, 2025 | 28.20 | 0.64 | 2.32% | 27.56 | 28.54 | 27.56 |
| Jan 30, 2025 | 28.16 | 0.89 | 3.26% | 27.27 | 28.41 | 27.27 |
| Jan 29, 2025 | 27.31 | 0.36 | 1.34% | 26.95 | 27.52 | 26.20 |
| Jan 28, 2025 | 26.98 | 0.76 | 2.90% | 26.22 | 27.24 | 25.82 |
| Jan 27, 2025 | 26.59 | 0.59 | 2.27% | 26.00 | 27.38 | 26.00 |
| Jan 24, 2025 | 26.35 | 0.40 | 1.54% | 25.95 | 26.84 | 25.83 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Castle Biosciences Inc. Company profile
About Castle Biosciences Inc
Castle Biosciences, Inc. is a commercial-stage dermatological cancer company. The Company provides physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The Company markets its three dermatologic products, DecisionDx-Melanoma, DecisionDx-SCC and DecisionDx DiffDx-Melanoma. It also market DecisionDx-UM, a gene expression profiling (GEP) test. It developed and market DecisionDx-Melanoma to healthcare providers for use with patients diagnosed with invasive cutaneous melanoma. It developed DecisionDx-SCC, a 40-gene expression profile test that uses an individual patient’s tumor biology to predict individual risk of squamous cell carcinoma metastasis for patients with one or more risk factors. It developed DecisionDx DiffDx-Melanoma, a GEP test designed to be used as an adjunct to histopathology when the distinction between a benign lesion and melanoma is uncertain.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Castle Biosciences Inc revenues increased 50% to $94.1M. Net loss increased from $10.3M to $31.3M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Selling, General and Administrative. increase of 68% to $70.9M (expense), Research & Development - Balancing value increase from $11.7M to $24.9M (expense).
| Industry: | Laboratory Diagnostic & Testing Substances |
505 S Friendswood Drive
2014 San Miguel Dr
FRIENDSWOOD
TEXAS 77546
US
News
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025
Ripple XRP price prediction: Third-party price target
Discover the ripple (XRP) price predictions for 2025 and beyond, with analyst price targets and CFDs trading strategies on Capital.com
15:29, 6 February 2025
Apple (AAPL) stock price forecast: third-party price target
We looked at the forecasts for Apple stock in 10 years to see where the price would likely be at that point and the challenges the company could face. Read more.
11:22, 6 February 2025
FARTCOIN price prediction: Third-party price target
Read our FARTCOIN price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:18, 29 January 2025
MELANIA coin ($MELANIA) price prediction: Third party price target
Read our MELANIA crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts.
11:33, 22 January 2025
TRUMP coin ($TRUMP) price prediction: third-party price target
Read our TRUMP crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:52, 22 January 2025
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025People also watch
Still looking for a broker you can trust?
Join the 690,000+ traders worldwide that chose to trade with Capital.com